Abstract:The frog skin host-defense peptide tigerinin-1R (RVCSAIPLPICH.NH2) is insulinotropic both in vitro and in vivo. This study investigates the effects on insulin release and cytotoxicity of changes in cationicity and hydrophobicity produced by selected substitutions of amino acids by l-arginine, l-lysine and l-tryptophan. The [A5W], [L8W] and [I10W] analogs produced a significant (P<0.01) increase in the rate of insulin release from BRIN-BD11 rat clonal β cells at concentration of 0.01 nM compared with 0.1 nM for tigerinin-1R. The increase in the rate of insulin release produced by a 3 μM concentration of the [S4R], [H12K], and [I10W] analogs from both BRIN-BD11 cells and mouse islets was significantly greater (P<0.05) than that produced by tigerinin-1R. No peptide stimulated the release of lactate dehydrogenase at concentrations up to 3 μM indicating that plasma membrane integrity had been preserved. [A5W] tigerinin-1R was the only analog tested that showed cytotoxic activity against human erythrocytes (LC50=265 ± 16 μM) and inhibited growth of Escherichia coli (MIC=500 μM) and Staphylococcus aureus (MIC=250 μM). The circular dichroism spectra of tigerinin-1R and [A5W] tigerinin-1R indicate that the peptides adopt a mixture of β-sheet, random coil and reverse β-turn conformations in 50% trifluoroethanol/water and methanol/water. Administration of [S4R] tigerinin-1R (75 nmol/kg body weight) to high-fat fed mice with insulin resistance significantly (P<0.05) enhanced insulin release and improved glucose tolerance over a 60 min period following an intraperitoneal glucose load. The study supports the claim that tigerinin-1R shows potential for development into novel therapeutic agents for treatment of type 2 diabetes mellitus.

Isolation and Purification of a Novel Insulinotropic Peptide from the Skin Secretions of Odorrana Grahami and the Study of Its Bioactivities

Isolation and structural characterization of novel Rugosin A-like insulinotropic peptide from the skin secretions of Rana saharica frog

Isolation,Characterization and Biological Activity of A Novel Peptide from Sika(Cervus nippon Temminck) Antler

Isolation, Purification and Functional Analyses of Rat Islets

Insulin-releasing and cytotoxic properties of the frog skin peptide, tigerinin-1R: a structure-activity study

Identification of Novel Peptides from Goat Milk Casein That Ameliorate High-Glucose-induced Insulin Resistance in HepG2 Cells.

Purification and Identification of a Novel Antidiabetic Peptide from Chinese Giant Salamander (andrias Davidianus) Protein Hydrolysate Against Α-Amylase and Α-Glucosidase

Identification and Function Analysis of Novel Hypoglycemic and Antioxidant Peptides from Chickpea

PURIFICATION AND CHARACTERIZATION OF A NEW PEPTIDE (S-8300) FROM SHARK LIVER: PURIFICATION AND CHARACTERIZATION

Experimental Studies on Islets Isolation, Purification and Function in Rats.

Isolation, Purification and Activity of A Novel Antimicrobial Peptide from Skin of Rana Catesbeiana

Isolation,Purification and Bioactivity of A Novel Lipopeptide

Purification, characterization and hypoglycemic activity of glycoproteins obtained from pea (Pisum sativum L.)

Preparation and Identification of Hypoglycemic Bioactive Peptide from Amygdalus Communis L. by Multienzyme Hydrolysis

Mechanistic Study of Novel Dipeptidyl Peptidase IV Inhibitory Peptides from Goat’s Milk Based on Peptidomics and in Silico Analysis

Isolation of Peptide Inhibiting SGC-7901 Cell Proliferation from Aspongopus chinensis Dallas

Identification and bioactivity evaluation of a novel bradykinin inhibitory peptide from the skin secretion of Chinese large odorous frog, Odorrana livida

Purification and Identification of Anti-Obesity Peptides Derived from Spirulina Platensis

A Novel Glucagon-Like Peptide 1 Peptide Identified from Ophisaurus Harti.

Isolation, Purification and Assessment of Rat Pancreas Islet

Separation, identification, and design of α-glucosidase inhibitory peptides based on the molecular mechanism from Paeonia ostii 'Feng Dan' seed protein.